Neuroendocrine Tumor Southern Africa Support. NETSAS provides support for NETs patients and empowers patients with knowledge
Cape Town, South Africa
Joined October 2023
- Tweets167
- Following73
- Followers41
- Likes494
NETSAS retweeted
📢#NETCancerDay is on November 10th.
NETs are easily missed but early diagnosis is possible. 📌Please prepare to join the global NET community to speak in one global voice.
📌Check out INCA’ campaign toolkit for guidance how to get involved in NET Cancer Day: incalliance.org/ncd-2025/cam…
#LetsTalkAboutNETs
NETSAS retweeted
📣Patients. Caregivers. Healthcare professionals.
Together, we can transform NET care.
📌Join the #SCAN2025 Global Survey and help shape the future of diagnostics & treatment worldwide.
✅Take the survey today: incalliance.org/scan2025/
#LetsTalkAboutNETs #WeSCAN #MedTwitter
NETSAS retweeted
💻Check out our collections of video presentations by prominent NEN researchers to be abreast of the latest in NEN clinical trials: incalliance.org/researcher-i…
🌎Available in English with captions in French, German, Italian, Portuguese and Spanish.
#LetsTalkAboutNETs #OncTwitter
NETSAS retweeted
Obrixtamig, a DLL3/CD3 IgG-like T-cell engager for SCLC and epNECs. Just out in JCO. Clearly efficacy in these hard-to-treat cancers and larger studies ongoing will hopefully confirm that.
ascopubs.org/doi/10.1200/JCO…
NETSAS retweeted
NENs are often missed in general practice.
🎯The #ThinkNENs program gives you the tools to spot them early.
📌Free. Online. CME-accredited.
✅Get proficient in just 60 mins: incalliance.org/think-nens/
#LetsTalkAboutNETs
NETSAS retweeted
🔔Calling all #PrimaryCarePhysicians: Enroll in the free #ThinkNENs e-learning designed for busy general practitioners and get a free CME credit: incalliance.org/think-nens/
🔔Get proficient in detecting this uncommon cancer to save lives.
#LetsTalkAboutNETs #MedTwitter #EndoTwitter #LungTwitter #MedED
NETSAS retweeted
#PrimaryCarePhysicians are the first to see NET patients when symptoms present. Among the repetitive diagnoses of common conditions, it is difficult to suspect the uncommon.
📌We help PCPs to detect NENs with a 60-minutes e-learning and a free CME credit.
✔️Check it out here: incalliance.org/think-nens/ #LetsTalkAboutNETs
NETSAS retweeted
6000 newly diagnosed NENs a year in England alone. ~ 16 a day, ~ 1 every 90 minutes. Not as rare as we keep being told they are. And these figures exclude some types. buff.ly/ffdMkp8
NETSAS retweeted
📌Dr. Grace Kong: “The future focus should be on performing more multicenter collaborative studies on NENs.”
☑️Learn about the latest nuclear medicine clinical trials related to NENs: incalliance.org/dr-grace-kon… #LetsTalkAboutNETs #RadTwitter
NETSAS retweeted
ICYMI: We released our 1st guideline to aid oncologists in managing symptoms of GEP-NETs—complex diseases that can take a toll on patient function & quality of life. #ASCODailyNews has more, including comments from Expert Panel Co-Chair @JaydiDelRivero: brnw.ch/21wSCdU
NETSAS retweeted
Neuroendocrine Cancer? – 10 questions to ask your doctor ronnyallan.net/2024/05/12/ne…
NETSAS retweeted
On the #WorldFamilyDoctorsDay, we would like to praise the key role #PrimaryCarePhysicians play in timely diagnosis and patient management.
✅Share with your family doctor the free #ThinkNENs e-learning program with CME credit in 6 languages: incalliance.org/think-nens/
#LetsTalkAboutNETs
NETSAS retweeted
Behind a NET diagnosis there is a personal story.
👉Karin from Belgium spent 6 years with symptoms of low blood pressure, hot flashes, tiredness, abdominal pain. She visited her GP every 6 months. NET awareness would have urged referral for scan.
✅Watch Karin’s story: incalliance.org/stories/kari…
#LetsTalkAboutNETs
NETSAS retweeted
The neuroendocrine system bridges the nervous & endocrine systems, influencing everything from gut function to immune response.
It’s also central to understanding complex cancers like neuroendocrine cancer.
NETSAS retweeted
There is a consensus among NET researchers - clinical trials should be patient-centered.
🔔Now the INCA collection of NET researchers’ insightful videos is available with captions in 5 languages: French, German, Italian, Portuguese and Spanish: incalliance.org/researcher-i…
#LetsTalkAboutNETs
NETSAS retweeted
📢Today is #WorldHealthDay! The global NET patient community honors all healthcare professionals who support the patients in diagnosis, treatment and care. 👏Thank you for your dedication!
📌Let’s help more HCPs learn about NETs: incalliance.org/net-info-pac…
#LetsTalkAboutNETs #MedEd
NETSAS retweeted
Big news for #NETs! But let’s be real… 60 mg was like a bad first date: too intense, hard to tolerate. So, we’re dialing it down to 40 mg in our study to find the sweet spot! Stay tuned! #ClinicalResearch clinicaltrials.gov/study/NCT…
@MattZibelman @FoxChaseCancer @NCCN
#Cabozantinib is now @US_FDA approved based off #CABINET study for previously treated pNET or epNET.
- ⬆️ PFS in both subsets
- mPFS pNET 11.4mos Vs 3mos and epNET 8.5mos Vs 5.6mos
- SE: HTN, Diarrhea, Fatigue
#OncTwitter #MedTwitter @NANETS1 @LACNETS #gism @OncoAlert
NETSAS retweeted
Big news for NET patients!
#Cabozantinib is now @US_FDA approved based off #CABINET study for previously treated pNET or epNET.
- ⬆️ PFS in both subsets
- mPFS pNET 11.4mos Vs 3mos and epNET 8.5mos Vs 5.6mos
- SE: HTN, Diarrhea, Fatigue
#OncTwitter #MedTwitter @NANETS1 @LACNETS #gism @OncoAlert
NETSAS retweeted
Breaking news:
The U.S. FDA approved Cabozantinib (@ExelixisInc) for patients 12 and older with previously treated, advanced #NeuroendocrineTumors. For details, please visit bit.ly/3DTtTPu.
Watch our interviews with Dr. Jennifer Chan on the #CABINET results: ncf.net/post/positive-result…
@NANETS @NETCancerDay @CarcinoidNETs @HealingNET1 #OncTwitter #MedTwitter
